TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06661850: Examination of Nociscan Impact on Low Back Pain Surgical Outcomes

Sponsor: Aclarion · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 300 pts

Competing Trials Overlap

8 Active Trials

Excess Burn Exposure

$6,042,400

Rescue Site Savings

+$3,984,000

Unlock Full NCT06661850 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06661850 Rescue Dossier →